Classical Hodgkin Lymphoma Recurrent

Oncology·MeSH: Parkinson Disease 4, Autosomal Dominant Lewy Body

Prevalence

56.0 / 100K

Incidence

19.6 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Classical Hodgkin Lymphoma Recurrent?

There are 1 clinical trial targeting Classical Hodgkin Lymphoma Recurrent tracked by BioSniper.

What is the prevalence of Classical Hodgkin Lymphoma Recurrent?

The estimated prevalence of Classical Hodgkin Lymphoma Recurrent is approximately 56.0 per 100,000 population.

Deep-dive into Classical Hodgkin Lymphoma Recurrent

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Classical Hodgkin Lymphoma Recurrent — Drugs in Development & Clinical Trials | BioSniper